First Data Bank License Agreement Renewal
ID: OIT-393-2024-0833Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR MEDICARE AND MEDICAID SERVICESOFC OF ACQUISITION AND GRANTS MGMTBALTIMORE, MD, 21244, USA

NAICS

Directory and Mailing List Publishers (513140)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/46e6b9dda20c4cd790ead456bf10dbe7/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Medicare and Medicaid Services (CMS), intends to negotiate a sole source contract for the renewal of the First Data Bank License Agreement. This procurement aims to secure four user licenses for essential data and standards, including the National Drug Data File (NDDF) and the RX norm cross-reference model, which are critical for the administration of the Medicare Part D program and support fraud detection and reimbursement decisions. The contract will ensure continued access to vital drug data and maintenance of the Integrated Data Repository (IDR) and Prescription Information (PI) products, with a performance period from September 30, 2024, to September 29, 2025. Interested vendors must submit their capability statements and pricing proposals to Phillip Harrell at phillip.harrell@cms.hhs.gov within five days of this notice.

    Files
    Title
    Posted
    OIT-393-2024-0833 STATEMENT OF WORK FOR FIRST DATA BANK 2024.docx
    The contract with First Data Bank, Inc. aims to provide four user licenses for essential data and standards for the Centers for Medicare and Medicaid Services (CMS) staff and contractors, along with renewing maintenance for the Integrated Data Repository (IDR) and the Prescription Information (PI) products. This initiative follows an existing license agreement with First Data Bank, renewing access to the RX norm cross-reference model essential for electronic drug delivery to CMS. The data is vital for the administration of the Medicare Part D program, facilitating fraud detection and reimbursement decisions for approved drugs. The performance period for this contract spans from September 30, 2024, to September 29, 2025. This summary underscores the necessity of these tools in the ongoing management and oversight of Medicare services, as mandated by the Medicare Modernization Act of 2003, ensuring proper data access and maintenance for effective program execution.
    Lifecycle
    Title
    Type
    First Data Bank License Agreement Renewal
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Facility Management System (FMS) Administration and Data Management
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the administration and data management of its Facility Management System (FMS), utilizing the ARCHIBUS software. The contractor will be responsible for providing ongoing FMS support, ensuring compliance with federal reporting requirements, maintaining data integrity, and offering user training and technical assistance. This initiative is crucial for managing the FDA's facilities efficiently in response to increasing service demands and regulatory requirements, with the contract anticipated to span from March 24, 2025, to March 23, 2030. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by September 23, 2024, at 2:00 PM EST, as this is a Sources Sought Notice and not a solicitation for proposals.
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. This acquisition aims to secure compounded, patient-ready doses of the radiopharmaceutical, which is critical for diagnosing and treating diseases in accordance with patient care protocols. The drugs are FDA-approved and must be compounded and delivered on a time-sensitive basis due to their rapid radiation decay, making Sofie Co. the only authorized provider capable of meeting these specialized requirements. Interested parties may submit capability statements by September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals.
    Intent to Sole Source RS Means Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract with The Gordian Group, Inc. for the licensing of RS Means Software. This software is essential for enhancing the accuracy and efficiency of the NIH's construction cost estimation processes, providing reliable and up-to-date cost data critical for project planning and budgeting. The acquisition of RS Means is vital for ensuring precise estimates that reflect current market trends, thereby reducing the risk of cost overruns and improving overall project management. Interested parties that believe they can meet these requirements must respond within five days of the notice, providing necessary company information, as the contract is set to be awarded as a firm-fixed-price purchase order for a one-year period, from September 23, 2024, to September 22, 2025. For further inquiries, contact Amanda Tilton at amanda.tilton@nih.gov or call 301-594-5711.
    Software Bill of Materials (SBOM) Validation Comparison Set
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration's Center for Devices and Radiological Health (CDRH), is seeking to award a firm fixed price purchase order to MedCrypt, Inc. for the development of a Software Bill of Materials (SBOM) Validation Comparison Dataset. The primary objective of this procurement is to enhance cybersecurity for medical devices by providing a continuously updated dataset of known vulnerabilities, which will aid in the analysis of risks and potential exploits associated with software components used in these devices. This initiative is crucial for ensuring the safety and efficacy of healthcare technologies, particularly in light of recent legislative mandates under the Food and Drug Omnibus Reform Act of 2022. Interested parties can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov for further information regarding this opportunity.
    DH01--Data Innovations Instrument Management Interfacing System Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 4, intends to sole source a contract for the Data Innovations Instrument Manager software, which is critical for integrating laboratory analyzers with the VistA system at the Erie VA Medical Center. This procurement aims to secure additional license connections and ongoing maintenance and support for the software, ensuring compliance with VA standards and enhancing laboratory operations. The contract will be negotiated with Data Innovations, LLC, under FAR 13.106-1, and interested vendors must submit a one-page capability statement by September 17, 2024, to the Contract Specialist, Christa L. Stine, at christa.stine@va.gov. This opportunity emphasizes the importance of compliance, security, and the structured procurement process to improve services for veterans.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Subscription to news, schedules, federal budget and appropriations
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to procure subscriptions to Budget Tracker for six individuals, aimed at enhancing legislative tracking and budget monitoring capabilities. The procurement includes a base year subscription with options for four additional years, providing essential documents related to appropriation bills, detailed bill status charts, and legislative analysis. These subscriptions are critical for the FDA's Office of Regulatory Affairs to maintain continuous access to vital financial and legislative information, particularly during periods of congressional delays in finalizing appropriations. Interested vendors should contact Valrica Manns at valrica.manns@fda.hhs.gov or call 301-837-7507 for further details, with the anticipated period of performance extending from August 2024 to August 2029.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for the establishment of Blanket Purchase Agreements (BPA) and Additional Discount Program (ADP) agreements related to pharmaceutical agents under the Defense Health Agency's Uniform Formulary (UF). This procurement aims to secure pricing agreements for various newly approved drugs, including those in the classes of Parkinson's agents, gastrointestinal agents, respiratory agents, hematological agents, targeted immunomodulatory biologics, anticonvulsants, and oncological agents, which will be reviewed during the Pharmacy and Therapeutics (P&T) Committee meeting scheduled for November 6-7, 2024. The initiative is crucial for maintaining an effective pharmacy benefits program for the Military Health System (MHS), ensuring that military personnel have access to high-value medications while adhering to cost-effectiveness criteria. Interested manufacturers must submit their quotes by September 19, 2024, and can direct inquiries to primary contact Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or secondary contact Tracy Banks at tracy.e.banks2.civ@health.mil.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    INTENT TO SOLE SOURCE - CAREFUSION for Pyxis rental with full support
    Active
    Health And Human Services, Department Of
    Special Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF intends to negotiate a sole source contract with CareFusion Solutions for Pyxis rental with full support. Pyxis is a drug automated distribution system that controls the availability, access distribution, and patient safety. The contract will be in effect from the date of award to March 31, 2025. This is a non-competitive procurement based on exclusive licensing agreement. Other potential sources may submit a capability statement by July 24th, 2024.